<DOC>
	<DOCNO>NCT01894724</DOCNO>
	<brief_summary>This study design evaluate safety feasibility NeuroSave device rapidly reduce brain temperature maintain brain low temperature body core cardiac surgery .</brief_summary>
	<brief_title>Targeted Hypothermia During Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hypothermia</mesh_term>
	<criteria>â‰¥18 year age Undergoing coronary revascularization valvular cardiac surgery The study patient study patient 's legal representative inform nature study , agree provision provide write informed consent approve Human Research Ethics Committee ( HREC ) respective clinical site The study patient agree comply study related procedure Women know suspected pregnant ( confirmed pregnancy test woman childbearing age ) Past history cerebrovascular accident ( stroke TIA ) History clinically diagnose active psychiatric condition Emergency salvage cardiac valve operation Body weight &lt; 50 kg Leukopaenia ( WBC &lt; 3000 cell/mL ) , anaemia ( Hgb &lt; 11g/dL ) , Thrombocytopaenia ( Plt &lt; 50,000 cell/mL ) Active upper GI bleeding within 3 month ( 90 day ) prior procedure Renal insufficiency ( creatinine &gt; 265 micromol/L ) and/or renal replacement therapy time screen Estimated life expectancy &lt; 12 month ( 365 day ) Structural abnormality disease nose , mouth , pharynx oesophagus ( exclude gastric reflux oesophagus disease ) , Currently participate investigational drug another device study would potentially impact result study determined PI . Note : Trials require extend followup product investigational , since become commercially available , consider investigational trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>